Patents by Inventor Uwe Moller
Uwe Moller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220063411Abstract: In a method for adjusting a vehicle component a function of an operating element is selected by a first operating process and the vehicle component is adjusted by a second operating process carried out manually on the operating element. The first operating process is caused by a speech input, a gesture, and/or a gaze.Type: ApplicationFiled: October 23, 2019Publication date: March 3, 2022Inventors: Paul HEISTERKAMP, Klaus BADER, Andreas LUFT, Carsten-Uwe MÖLLER, Frank REH, Felix SCHÜSSEL
-
Publication number: 20080113380Abstract: The invention provides methods for detecting an analyte in a sample including the steps of: (a) exciting a sensitizer label on an analyte; (b) permitting energy from the excited sensitizer label to be transferred to and excite an acceptor molecule, whereby the sensitizer label returns to an unexcited state; (c) reacting the excited acceptor molecule with a chemiluminescent precursor to form a chemiluminescent compound which emits light in response to an activation source; (d) exposing the chemiluminescent compound to the activating source to produce a detectable signal; (e) detecting the signal; and (f) correlating the signal with the presence or absence of the analyte. The chemiluminescent precursor is desirably an olefin capable of being converted to a 1,2-dioxetane. Target amplification techniques, such as PCR, may be used to directly label a target analyte with a sensitizer.Type: ApplicationFiled: January 18, 2008Publication date: May 15, 2008Applicant: EMP BIOTECH GMBHInventors: Derek Levison, Uwe Moller, Stuart Levison
-
Patent number: 7104071Abstract: A gas turbine group is provided with at least one cooling apparatus for cooling the working medium before and/or during the compression. The cooling power of the cooling apparatus can be adjusted by suitable means. A controller controls the cooling power of the cooling apparatus as a function of a control deviation in the useful power of the gas turbine group. The cooling controller interacts with other controllers of the gas turbine group in such a way that the gas turbine group is itself always operated at least close to its full load operating state. In this context, it is preferable for the inlet guide vane row of the compressor to be maximally open, and for the hot-gas temperature on entry into the turbines to be controlled so that it is constantly at an upper limit value.Type: GrantFiled: July 7, 2004Date of Patent: September 12, 2006Assignee: ALSTOM Technology LtdInventors: Jost Braun, Jürgen Hoffmann, Uwe Möller
-
Patent number: 6911305Abstract: The invention provides chemiluminescent assays that incorporate a film including at least one chemiluminescent precursor immobilized therewith which produces a triggerable chemiluminescent compound, the film being free of compounds which generate singlet oxygen and being adapted for use with a sensitizer-labeled agent or agent probative of the analyte.Type: GrantFiled: March 30, 2004Date of Patent: June 28, 2005Assignee: emp Biotech GmbHInventors: Derek W. K. Levison, Uwe Moller, Stuart Levison
-
Publication number: 20050109033Abstract: A gas turbine group is provided with at least one cooling apparatus for cooling the working medium before and/or during the compression. The cooling power of the cooling apparatus can be adjusted by suitable means. A controller controls the cooling power of the cooling apparatus as a function of a control deviation in the useful power of the gas turbine group. The cooling controller interacts with other controllers of the gas turbine group in such a way that the gas turbine group is itself always operated at least close to its full load operating state. In this context, it is preferable for the inlet guide vane row of the compressor to be maximally open, and for the hot-gas temperature on entry into the turbines to be controlled so that it is constantly at an upper limit value.Type: ApplicationFiled: July 7, 2004Publication date: May 26, 2005Inventors: Jost Braun, Jurgen Hoffmann, Uwe Moller
-
Publication number: 20050074815Abstract: The invention provides chemiluminescent assays that incorporate a film including at least one chemiluminescent precursor immobilized therewith which produces a triggerable chemiluminescent compound, the film being free of compounds which generate singlet oxygen and being adapted for use with a sensitizer-labeled agent or agent probative of the analyte.Type: ApplicationFiled: March 30, 2004Publication date: April 7, 2005Applicant: emp Biotech GmbHInventors: Derek Levison, Uwe Moller, Stuart Levison
-
Patent number: 6764819Abstract: The invention provides chemiluminescent assays that incorporate a film including at least one chemiluminescent precursor immobilized therewith which produces a triggerable chemiluminescent compound, the film being free of compounds which generate singlet oxygen and being adapted for use with a sensitizer-labeled agent or agent probative of the analyte.Type: GrantFiled: July 16, 2002Date of Patent: July 20, 2004Assignee: emp Biotech GmbHInventors: Derek W. K. Levison, Uwe Moller, Stuart Levison
-
Publication number: 20040014200Abstract: The invention provides chemiluminescent assays that incorporate a film including at least one chemiluminescent precursor immobilized therewith which produces a triggerable chemiluminescent compound, the film being free of compounds which generate singlet oxygen and being adapted for use with a sensitizer-labeled agent or agent probative of the analyte.Type: ApplicationFiled: July 16, 2002Publication date: January 22, 2004Applicant: emp Biotech GmbH.Inventors: Derek W.K. Levison, Uwe Moller, Stuart Levison
-
Publication number: 20040014043Abstract: The invention provides methods for detecting an analyte in a sample including the steps of: (a) exciting a sensitizer label on an analyte; (b) permitting energy from the excited sensitizer label to be transferred to and excite an acceptor molecule, whereby the sensitizer label returns to an unexcited state; (c) reacting the excited acceptor molecule with a chemiluminescent precursor to form a chemiluminescent compound which emits light in response to an activation source; (d) exposing the chemiluminescent compound to the activating source to produce a detectable signal; (e) detecting the signal; and (f) correlating the signal with the presence or absence of the analyte. The chemiluminescent precursor is desirably an olefin capable of being converted to a 1,2-dioxetane. Target amplification techniques, such as PCR, may be used to directly label a target analyte with a sensitizer.Type: ApplicationFiled: July 16, 2002Publication date: January 22, 2004Applicant: emp Biotech GmbHInventors: Derek W.K. Levison, Uwe Moller, Stuart Levison
-
Patent number: 6613578Abstract: The present invention relates to chemiluminescent assays which incorporate a second film or membrane which includes a solid chemical component for activation of a stable dioxetane. Decomposition of the stable dioxetane can be accomplished using a combination of heat and chemical treatment.Type: GrantFiled: June 4, 2002Date of Patent: September 2, 2003Assignee: EMP Biotech GmbHInventors: Uwe Moller, Derek Levison, Stuart Levison
-
Patent number: 6411934Abstract: The invention describes an operating system which comprises a voice-operated device and an actuating device, various operating functions being assigned to the actuating device by means of the voice-operated device. According to the invention, the actuating device has several degrees of adjusting freedom and types of a haptic acknowledgment which can be set depending on the assigned operating function.Type: GrantFiled: February 25, 1997Date of Patent: June 25, 2002Assignee: DaimlerChrysler AGInventors: Carsten-Uwe Möller, Frank Reh